Search Results for genedrive


UK recommends Genedrive test, shares jump

Manchester-based Genedrive plc said UK medical authorities have recommended its genetic test for stroke sufferers before they use anti-blood clotting drugs, which should increase sales…



Genedrive shares up 50% on stroke test news

Shares of Manchester-based Genedrive, a “point of care pharmacogenetic testing company,” rose as much as 50% after it announced news from the UK’s National Institute for…



Genedrive shares rise amid testing kit news

Shares of Manchester-based molecular diagnostics company Genedrive rose about 10% after it announced the UK’s National Institute for Health and Care Excellence (NICE) has recommended in draft guidance…


Genedrive shares up 140% in 2023 amid NHS news

Shares of Manchester-based molecular diagnostics company Genedrive rose as much as 20% on Thursday after it said the UK’s National Institute for Health and Care Excellence (NICE) has…


Genedrive shares fall 20% as loss widens

Shares of Manchester-based molecular diagnostics company Genedrive fell about 20% on Monday after the firm reported a substantially widened pretax loss as revenue slumped due to a lack…


Genedrive shares up 30% amid FDA pre-submission

Shares of Manchester-based molecular diagnostics company Genedrive rose about 30% after it announced it has commenced engagement with the US Food and Drug Administration (FDA) “to progress…


Genedrive shares up on Covid test approval

Shares of Manchester-based molecular diagnostics company Genedrive rose about 5% on Monday after the UK Medicines and Healthcare Products Regulatory Agency granted the firm a Coronavirus Test…


Genedrive shares up 20% on Covid kit news

Shares of Manchester-based molecular diagnostics company Genedrive rose as much as 20% on Wednesday after it announced that “expanded product validation requirements have now been completed ”…



Genedrive soars 280% on coronavirus test news

Shares of Manchester-based molecular diagnostics company Genedrive soared more than 280% on Wednesday after it issued a trading update saying it has “refocussed a significant part…